logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Novellus Closes $57M Series C Financing

Novellus Closes $57M Series C Financing

09/21/20, 1:07 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/IL.svgjerusalem
Money raised
$57 million
Round Type
series c
Novellus, Ltd., a clinical-stage biotechnology company focused on precision oncology announced today that it has raised $57 million in a Series C financing round. The round was led by Pontifax, and joined by OrbiMed Advisors, HBM Healthcare Investments, Wellington Management, Cormorant Asset Management, Novartis Venture Fund (NVF), SR One, as well as existing investors.

Company Info

Company
Novellus
Location
jerusalem, jerusalem district, israel
Additional Info
Novellus is a clinical-stage drug development company. Novellus focuses on the development of compounds for established oncogene drivers with a high incidence of uncharacterized mutations. Novellus’ leading project, PLX-8394, is in clinical development (NCT02428712).
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.